次に

自動再生

ALK mutations in paediatric tumours

4 ビュー • 07/30/23
シェア
埋め込む
administrator
administrator
加入者
0

Dr Turner speaks with ecancer at Childhood Cancer 2016 about her work, made possible by a project grant from Children with Cancer UK.

She describes the role of ALK activity in the aetiology anaplastic large cell lymphoma, and as a target for paediatric therapies following the success of crizotinib in treating ALK lung cancer.

Considering the mechanisms of resistance, Dr Turner outlines how her research into screening for 'bypass tracks' might circumvent resistance in childhood disease.

もっと見せる
0 コメント sort 並び替え
フェイスブックのコメント

次に

自動再生